Jim Cramer on Biohaven: “The Stock Seems Very Low to Me”

Biohaven Ltd. (NYSE:BHVN) is one of the stocks Jim Cramer recently shed light on. During the lightning round, when a caller inquired about the stock, Cramer stated:

“Okay, well, I’ll tell you in full disclosure, I have a deal with Biohaven over a drug that I’ve invented with a doctor. So I will tell you the stock seems very low to me. But then again, because I do have that deal, you might just say, well, wait a second, Cramer’s, you know, how can you tell? But boy, is it low.”

Source: Unsplash

Biohaven Ltd. (NYSE:BHVN) develops treatments for neurological, psychiatric, autoimmune, and cancer-related conditions, with several drugs in clinical trials. A caller asked about the stock during the May 29 episode, and Cramer responded:

“Alright, Biohaven had an analyst day the other day, and it was, you know, people didn’t get excited about it. Now, in full disclosure, I do have a personal deal with Biohaven, and I don’t talk about it much because it’s not been disclosed, but I am surprised this stock is all the way down here. Vlad Coric is really good. I think that this is a buy, but you could say, hey Cramer, you’re biased, you got a deal with them. But I’m just telling you that’s how I feel, or else I wouldn’t have a deal with them.”

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.